Literature DB >> 21291271

An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.

Shan Gao1, Melissa J Simon, Christopher D Hue, Barclay Morrison, Scott Banta.   

Abstract

Cell penetrating pan class="Chemical">peptides (CPPs) have tremendous potential for use in gene and drug delivery applications. The selection of new CPPs with desired capabilities from randomized pepn>tide libraries is challenging, since the CPP phenotype is a compn>lex selection target. Here we repn>ort the discovery of an unusual new CPP from a randomized pepn>tide library using a functional selection system based on plasmid display (pan class="Disease">PD). After four rounds of screening of a 14-mer peptide library over PC12 cells, several peptides were identified and tested for their ability to deliver the green fluorescent protein (GFP). One peptide (SG3) exhibited a cell penetrating phenotype; however, unlike other well-known CPPs such as TAT or Penetratin, the newly identified peptide was not highly cationic. The PD protocol necessitated the addition of a cationic lipid (Lipofectamine2000), and in the presence of this compound, the SG3 peptide significantly outperformed the well-known TAT CPP in the delivery of GFP to PC12 cells and primary astrocytes. When the SG3 peptide was fused to the pro-apoptotic BH3 peptide from the Bak protein, significant cell death was induced in cultured primary astrocytes, indicating relevant, intracellular delivery of a functional cargo. The PD platform is a useful method for identifying functional new CPPs from randomized libraries with unique delivery capabilities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291271      PMCID: PMC3098927          DOI: 10.1021/cb100423u

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  51 in total

1.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

2.  The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells.

Authors:  Na Li; Peihui Lin; Chuanxi Cai; Zui Pan; Noah Weisleder; Jianjie Ma
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

Review 3.  Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.

Authors:  Tamaki Endoh; Takashi Ohtsuki
Journal:  Adv Drug Deliv Rev       Date:  2009-04-19       Impact factor: 15.470

4.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Authors:  Laurence Crombez; Gudrun Aldrian-Herrada; Karidia Konate; Quan N Nguyen; Gary K McMaster; Robert Brasseur; Frederic Heitz; Gilles Divita
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

5.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

6.  Identification and characterization of a novel cell-penetrating peptide.

Authors:  Jingwei Sheng; George Oyler; Bin Zhou; Kim Janda; Charles B Shoemaker
Journal:  Biochem Biophys Res Commun       Date:  2008-12-11       Impact factor: 3.575

7.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

Review 8.  Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.

Authors:  G M K Poon; J Gariépy
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

Review 9.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.

Authors:  Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

10.  A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expression.

Authors:  Arjuna Kumarasuriyar; Christian Dombrowski; David A Rider; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-09-21       Impact factor: 3.156

View more
  5 in total

1.  Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu
Journal:  J Vis Exp       Date:  2015-03-25       Impact factor: 1.355

2.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.

Authors:  Zhengrong Guo; Huanyan Peng; Jiwen Kang; Dianxing Sun
Journal:  Biomed Rep       Date:  2016-03-23

Review 3.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

4.  Protein delivery using Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu; Kimberly E Anderson; Shannon J Sirk; Carlos F Barbas
Journal:  ACS Chem Biol       Date:  2014-06-19       Impact factor: 5.100

5.  Cyclic Peptoid-Peptide Hybrids as Versatile Molecular Transporters.

Authors:  Claudine Nicole Herlan; Anna Meschkov; Ute Schepers; Stefan Bräse
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.